(Q41500150)

1 October 2017

1 reference

title

The calcium antagonist controversy: the emerging importance of drug formulation as a determinant of risk (English)

1 reference

1 October 2017

M Epstein

1

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

American Journal of Cardiology

1 October 2017

published in

1 reference

1 October 2017

volume

79

1 reference

1 October 2017

issue

10A

1 reference

1 October 2017

page(s)

9-19; discussion 47-8

1 reference

Current status of calcium channel blockers

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Do calcium channel blockers increase the risk of cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Calcium-channel blockade and incidence of cancer in aged populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Calcium antagonists: not appropriate as first line antihypertensive agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Nifedipine and mortality. Grave defects in the dossier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

The risk of myocardial infarction associated with antihypertensive drug therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Calcium antagonists: still appropriate as first line antihypertensive agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Nifedipine gastrointestinal therapeutic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Hemodynamic comparison of two nifedipine formulations in patients with essential hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Effects of nisoldipine therapy on myocardial perfusion and neuro-hormonal status in patients with severe ischaemic left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Prognostic value of 24-hour blood pressure variability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Nimodipine after resuscitation from out-of-hospital ventricular fibrillation. A placebo-controlled, double-blind, randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Proischemic complications of dihydropyridine calcium channel blockers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Transient myocardial ischemia during nifedipine therapy in stable angina pectoris, and its relation to coronary collateral flow and comparison with metoprolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Relation of antianginal efficacy of nifedipine to degree of coronary arterial narrowing and to presence of coronary collateral vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Nifedipine in ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Effects of propranolol and nifedipine on exercise-induced attack in patients variant angina: assessment by exercise thallium-201 myocardial scintigraphy with quantitative rotational tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Effect of nifedipine on dipyridamole thallium-201 myocardial scintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Effects of nifedipine on coronary perfusion; recent assessment by parametric digital subtraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Addition of nifedipine to maximal beta-blocker-nitrate therapy: effects on exercise capacity and global left ventricular performance at rest and during exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Attenuation of the circadian patterns of myocardial ischemia with nifedipine GITS in patients with chronic stable angina. N-CAP Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Shanghai trial of nifedipine in the elderly (STONE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Doppler flow and echocardiography in functional cardiac insufficiency: assessment of nisoldipine therapy. Results of the DEFIANT-II Study. The DEFIANT-II Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Calcium channel antagonists delay regression of androgen-dependent tissues and suppress gene activity associated with cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Ca2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

7 January 2021

Apoptosis and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Apoptosis and cancer: the failure of controls on cell death and cell survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Calcium-channel blockers and the clinician

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Chronic calcium antagonist use in carcinoma of the lung and colon: a retrospective cohort observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Incidence of and mortality from cancer in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Epidemiology faces its limits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Risk of breast cancer in relation to the use of rauwolfia alkaloids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

There's good news and not so good news

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

STOP-Hypertension 2: a prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Swedish Trial in Old Patients with Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

Calcium-mediated cell injury and cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900266-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(97)00266-X

1 reference

1 October 2017

1 reference